Literature DB >> 20132921

Inpatient hospitalization for gynecologic disorders in the United States.

Maura K Whiteman1, Elena Kuklina, Denise J Jamieson, Susan D Hillis, Polly A Marchbanks.   

Abstract

OBJECTIVE: The purpose of this study was to examine trends in hospitalizations for gynecologic disorders in the United States. STUDY
DESIGN: Data on hospitalizations from 1998-2005 among women 15-54 years old were from the Nationwide Inpatient Sample, a nationally representative survey of inpatient hospitalizations. Hospitalizations with a principal diagnosis of a gynecologic disorder were used to estimate rates per 10,000 women.
RESULTS: Gynecologic disorders accounted for 7% and 14% of all hospitalizations among women 15-44 and 45-54 years old, respectively. The most common diagnoses were uterine leiomyomas (rate = 27.5), menstrual disorders (rate = 12.3), endometriosis (rate = 9.5), genital prolapse (rate = 7.0), benign ovarian cysts (rate = 6.5), and pelvic inflammatory disease (rate = 6.1). The hospitalization rate for menstrual disorders increased from 9.8 in 1998 to 13.3 in 2005 (P trend < .001). In contrast, rates declined for pelvic inflammatory disease, genital prolapse, benign ovarian cysts, and endometriosis (P trend < .05) and were unchanged for uterine leiomyoma.
CONCLUSION: Gynecologic disorders are an important contributor to inpatient hospitalization among women in the United States. Published by Mosby, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20132921     DOI: 10.1016/j.ajog.2009.12.013

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  23 in total

1.  Lajjalu treatment of uterine prolapse.

Authors:  T M Shivanandaiah; T M Indudhar
Journal:  J Ayurveda Integr Med       Date:  2010-04

2.  Depressive symptoms and risk of uterine leiomyomata.

Authors:  Lauren A Wise; Se Li; Julie R Palmer; Lynn Rosenberg
Journal:  Am J Obstet Gynecol       Date:  2014-12-13       Impact factor: 8.661

3.  History of uterine leiomyoma and risk of endometrial cancer in black women.

Authors:  Lauren A Wise; Todd R Sponholtz; Lynn Rosenberg; Lucile L Adams-Campbell; Wendy Kuohung; Michael P LaValley; Julie R Palmer
Journal:  Cancer Causes Control       Date:  2016-02-29       Impact factor: 2.506

4.  Uterine fibroid incidence and growth in an ultrasound-based, prospective study of young African Americans.

Authors:  Donna D Baird; Stacy A Patchel; Tina M Saldana; David M Umbach; Tracy Cooper; Ganesa Wegienka; Quaker E Harmon
Journal:  Am J Obstet Gynecol       Date:  2020-02-24       Impact factor: 8.661

5.  Leiomyoma-related hospitalization and surgery: prevalence and predicted growth based on population trends.

Authors:  Mary Ellen Wechter; Elizabeth A Stewart; Evan R Myers; Rosanne M Kho; Jennifer M Wu
Journal:  Am J Obstet Gynecol       Date:  2011-07-20       Impact factor: 8.661

6.  Lifetime abuse victimization and risk of uterine leiomyomata in black women.

Authors:  Lauren A Wise; Julie R Palmer; Lynn Rosenberg
Journal:  Am J Obstet Gynecol       Date:  2013-01-04       Impact factor: 8.661

7.  Upsurge of chlamydial reinfection in a large Canadian city: an indication of suboptimal chlamydia screening practices?

Authors:  Mélissa Généeux; Pascale Leclerc; Lucie Bédard; Robert Allard
Journal:  Can J Public Health       Date:  2010 Sep-Oct

8.  Soy-based Infant Formula Feeding and Heavy Menstrual Bleeding Among Young African American Women.

Authors:  Kristen Upson; Quaker E Harmon; Shannon K Laughlin-Tommaso; David M Umbach; Donna D Baird
Journal:  Epidemiology       Date:  2016-09       Impact factor: 4.822

Review 9.  Epidemiology of Uterine Fibroids: From Menarche to Menopause.

Authors:  Lauren A Wise; Shannon K Laughlin-Tommaso
Journal:  Clin Obstet Gynecol       Date:  2016-03       Impact factor: 2.190

10.  Occupational risk factors for endometriosis in a cohort of flight attendants.

Authors:  Candice Y Johnson; Barbara Grajewski; Christina C Lawson; Elizabeth A Whelan; Stephen J Bertke; Chih-Yu Tseng
Journal:  Scand J Work Environ Health       Date:  2015-12-07       Impact factor: 5.024

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.